Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
Things are looking up!

FRANKFURT -(Dow Jones)- The European Commission today granted regulatory approval for Levitra, a drug product for the treatment of erectile dysfunction, to Bayer HealthCare, a future subgroup of Bayer AG , and to Glaxo SmithKline Plc. (GSK)

Werner Wenning, Chairman of the Board of Management of Bayer AG, regards today's licensing of Levitra as a significant factor to strengthen the pharmaceuticals business of Bayer HealthCare. "We welcome the European Commission's decision. This is an extremely important step for our pharmaceuticals business, as we believe that Levitra has the potential to become a new blockbuster," commented Werner Wenning on the decision from Brussels.

http://biz.yahoo.com/djus/030307/0748000221_1.html

Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Community Home
Speak Your Mind, Start Your Blog, Rate Your Stocks

Community Team Fools - who are those TMF's?
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.
Advertisement